Low striatal D2 receptor binding as assessed by [I-123]IBZM SPECT in patients with writer's cramp

被引:24
|
作者
Horstink, CA
Praamstra, P
Horstink, MWIM
Berger, HJC
Booij, J
VanRoyen, EA
机构
[1] UNIV NIJMEGEN HOSP,DEPT NUCL MED,NL-6500 HB NIJMEGEN,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,NL-1105 AZ AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,ACAD MED CTR,DEPT MED PSYCHOL,NL-1105 AZ AMSTERDAM,NETHERLANDS
来源
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1997年 / 62卷 / 06期
关键词
D O I
10.1136/jnnp.62.6.672-a
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:672 / 673
页数:2
相关论文
共 50 条
  • [21] Striatal D2 receptor binding in olanzapine treated patients estimated by 123I IBZM SPET (single photon emission tomography).
    Pilowsky, LS
    Busatto, GF
    Taylor, M
    Costa, DC
    Sharma, T
    Sigmundssen, T
    Ell, PJ
    Nohria, V
    Kerwin, RW
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 181 - 181
  • [22] Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson’s disease: an [123I]IBZM and [123I]FP-CIT SPECT study
    C. C. P. Verstappen
    B. R. Bloem
    C. A. Haaxma
    W. J. G. Oyen
    M. W. I. M. Horstink
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 502 - 507
  • [23] I-123 IBZM SPECT IN PATIENTS WITH ASYMMETRIC PARKINSONS-DISEASE
    KNABLE, MB
    COPPOLA, R
    HYDE, T
    LEE, KS
    GOREY, J
    WEINBERGER, D
    NEUROLOGY, 1994, 44 (04) : A281 - A282
  • [24] Comparison of methods for quantification of D2 dopamine receptor binding with I-123 IBF in clinical SPECT studies
    Yonekura, Y
    Inoue, T
    Onishi, Y
    Sadato, N
    Tsuchida, T
    Nakamura, S
    Uematsu, M
    Waki, A
    Kamoto, Y
    Shiozaki, T
    Yamamoto, K
    Ishii, Y
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 1204 - 1204
  • [25] QUANTIFICATION OF DOPAMINE-D(2) RECEPTOR-BINDING POTENTIAL IN THE STRIATUM WITH I-123 IBZM SPECT - TECHNICAL AND INTEROBSERVER VARIABILITY
    VERHOEFF, NPLG
    KAPUCU, O
    SOKOLEBUSEMANN, E
    VANROYEN, EA
    JANSSEN, AGM
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P209 - P209
  • [26] I-123-IBZM SPECT AND ASYMMETRY OF D2 RECEPTOR DENSITY IN THE BASAL GANGLIA OF SCHIZOPHRENIC-PATIENTS
    BAUER, U
    PUILLE, M
    ROSSMEIER, B
    FRANZ, M
    GALLHOFER, B
    BAUER, R
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 76 - 76
  • [27] Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT
    Klimke, A
    Larisch, R
    Janz, A
    Vosberg, H
    Müller-Gärtner, HW
    Gaebel, W
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1999, 90 (02) : 91 - 101
  • [28] D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT
    Tranquart, F
    Saliba, E
    Barantin, L
    Lanneau, M
    Simmer, L
    Guilloteau, D
    Baulieu, JL
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (01) : 36 - 40
  • [29] Striatal D2 receptors and response to L-Dopa in Parkinson's disease: A I-123-IBZM SPECT study
    Pizzolato, G
    Cagnin, A
    Ermani, M
    Dam, M
    Bracco, F
    Battistin, L
    Chierichetti, F
    Ferlin, G
    NEUROLOGY, 1997, 48 (03) : 25004 - 25004
  • [30] Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study
    Francisco Lomeña
    Ana M. Catafau
    Eduard Parellada
    Miquel Bernardo
    Mireia Font
    Fernando Gutiérrez
    Javier Pavía
    Psychopharmacology, 2004, 172 : 165 - 169